US 10787452
Compounds useful as inhibitors of ATR kinase
granted A61PA61P1/02A61P1/04
Quick answer
US patent 10787452 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18